
Novo Nordisk
NONOF | OTC
$37.01
-$0.37 (-0.99%)
At close: Oct 2, 2026, 3:58 PM ET
-0.99%
(1D)No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Market Cap $164.35B
1D Range
36.69 38.44
52W Range
34.00 64.75
Valuation (TTM)
PE 10.18
PB 6.19
EV/EBITDA 6.70
Valuation (NTM)
Forward PE 11.44
Forward PEG -1.61
Price Target N/A
Cash Flow
FCF Yield 5.7%
SBC Adj. FCF Yield 5.7%
SBC Impact N/A
Margins
Gross Margin 80.7%
Operating Margin 45.8%
FCF Margin 19.9%
Growth (CAGR)
Revenue 3Y | 5Y 25.6% |
19.8%
Dil EPS 3Y | 5Y 15.8% |
7.3%
FCF 3Y | 5Y 2.4% |
5.4%
Returns
ROA 19.6%
ROE 59.1%
ROIC 29.7%
Financial Health
Net Debt
kr80.33B ($12.69B)
Current Ratio 0.87
Interest Coverage 86.86
Dividends
Div Yield 4.86%
Payout Ratio 7.2%
FCF Payout Ratio 81.8%
Loading financial charts...
Profile
Novo Nordisk A/S operates as a prominent global pharmaceutical firm, dedicated to the discovery, development, production, and distribution of a wide array of medicinal products. Its extensive operatio...
Sector Healthcare
Industry Drug Manufacturers - General
Employees 68,794
IPO Date May 7, 2010
Website www.novonordisk.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove NONOF